id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-351085-t4rxu2hq	Ortoleva, J.	Intracranial Hemorrhage in COVID-19 Patients on ECMO: Challenges and Future Directions	2020-06-09		.txt	text/plain	565	50	38	1 Extracorporeal membrane oxygenation (ECMO) is occasionally being used to support COVID-19 patients refractory to optimal mechanical ventilation, neuromuscular blockade, prone positioning, and inhaled pulmonary vasodilators. [2] [3] [4] The extracorporeal life support organization (ELSO) has been releasing a set of regularly updated statistics for confirmed and possible COVID-19 patients receiving ECMO. 5 Among the most concerning findings in this data set is the rate of intracranial hemorrhage (ICH): reported to be 28 of 457 cases, or 6.1%. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America In-Hospital Neurologic Complications in Adult Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation: Results From the Extracorporeal Life Support Organization Registry Neurologic Injury in Adults Supported With Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: Findings From the Extracorporeal Life Support Organization Database Thrombosis and coagulopathy in COVID-19 patients requiring extracorporeal membrane oxygenation	./cache/cord-351085-t4rxu2hq.txt	./txt/cord-351085-t4rxu2hq.txt